Description
Premium Ambroxol Hydrochloride 30 mg, Guaiphenesin 50 mg & Levosalbutamol Sulphate 1 mg Syrup
Biophar Lifesciences introduces Nopgtus Syrup, a high-quality pharmaceutical formulation designed for the effective management of respiratory disorders. This syrup combines Ambroxol Hydrochloride 30 mg, Guaiphenesin 50 mg, and Levosalbutamol Sulphate 1 mg Syrup in a balanced ratio to provide symptomatic relief in patients suffering from cough, bronchitis, asthma, and other respiratory ailments.
Each component in Nopgtus Syrup has been carefully selected to provide a comprehensive solution: Ambroxol Hydrochloride works as a mucolytic agent to reduce the thickness of mucus, Guaiphenesin acts as an expectorant to facilitate easier cough clearance, and Levosalbutamol Sulphate serves as a bronchodilator to relieve airway constriction. The combination ensures rapid relief, making it suitable for both adults and children under medical supervision.
Manufactured under WHO-GMP standards, Nopgtus Syrup assures quality, efficacy, and safety in every batch. Its pleasant taste and smooth formulation make it easy for patients to consume, encouraging better compliance with the prescribed treatment.
How Nopgtus Syrup Works
Ambroxol Hydrochloride 30 mg is a potent mucolytic that breaks down thick and sticky mucus in the respiratory tract. By reducing the viscosity of mucus, it helps in clearing congestion, making breathing easier and improving overall lung function.
Guaiphenesin 50 mg works as an expectorant. It stimulates the respiratory tract to loosen and expel phlegm efficiently, which is particularly useful in conditions like bronchitis and cold-induced cough. This dual action of reducing mucus thickness and aiding expulsion ensures faster symptom relief.
Levosalbutamol Sulphate 1 mg is a beta-2 agonist that relaxes the muscles around the airways. This bronchodilatory effect helps patients breathe more comfortably, reducing wheezing and shortness of breath often associated with asthma or COPD.
The synergistic effect of these three ingredients makes Nopgtus Syrup a trusted choice for doctors and patients seeking relief from respiratory discomfort.
Benefits of Nopgtus Syrup
- Comprehensive Respiratory Relief
Nopgtus Syrup addresses multiple symptoms simultaneously, including cough, mucus congestion, and bronchial constriction. - Rapid Action
The combination of mucolytic, expectorant, and bronchodilator properties ensures fast and effective relief. - Patient-Friendly Formulation
With a smooth texture and pleasant taste, the syrup is easy to consume, particularly for children and elderly patients. - Quality Assurance
Biophar Lifesciences manufactures Nopgtus Syrup under strict WHO-GMP guidelines, ensuring every batch meets international standards of safety, purity, and efficacy.
Uses and Indications
Nopgtus Syrup is indicated for the management of:
- Acute and chronic bronchitis
- Asthma-related cough
- Respiratory tract infections with excessive mucus
- Cold-induced cough and chest congestion
- Chronic obstructive pulmonary disease (COPD)
It is intended for oral administration and should be used as prescribed by a healthcare professional. Regular use ensures symptomatic relief and supports overall respiratory health.
PCD Pharma Franchise Opportunity
Biophar Lifesciences offers an attractive PCD Pharma Franchise opportunity for Nopgtus Syrup. This allows entrepreneurs, distributors, and medical representatives to market this high-demand respiratory syrup under their brand with complete support from Biophar Lifesciences.
Key Advantages for Franchise Partners:
- Exclusive Marketing Rights: Franchise partners can operate in defined territories with minimal competition.
- High Demand Product: Respiratory care is a rapidly growing market segment, offering lucrative business potential.
- Marketing Support: Partners receive product literature, promotional materials, and sales guidance.
- Reliable Supply Chain: Timely product delivery ensures that partners can maintain consistent stock for their customers.
This franchise model is ideal for businesses looking to expand in the respiratory care segment with a product like Pharma Franchise Ambroxol Hydrochloride 30 Mg, Guaiphenesin 50 Mg & Levosalbutamol Sulphate 1 Mg Syrup (Nopgtus Syrup) which is trusted for its efficacy and patient-friendly formulation.
Third-Party Manufacturing Services
Biophar Lifesciences also provides Third Pharty Manufacturing Ambroxol Hydrochloride 30 Mg, Guaiphenesin 50 Mg & Levosalbutamol Sulphate 1 Mg Syrup. Companies seeking to market the syrup under their own brand can leverage Biophar’s state-of-the-art facilities to ensure high-quality production.
Advantages of Third-Party Manufacturing:
- Cost Efficiency: Avoid the high investment of setting up manufacturing units.
- Regulatory Compliance: All production is carried out under WHO-GMP-certified facilities, ensuring international quality standards.
- Custom Branding: Packaging and labeling can be tailored to the client’s brand.
- Timely Production & Delivery: Biophar ensures production schedules are met to fulfill market demand efficiently.
This service allows pharmaceutical companies to enter the respiratory segment without the burden of production infrastructure while offering a reliable, high-quality product.
Packaging and Availability
Nopgtus Syrup is available in 1000 units, making it convenient for distributors, franchise partners, and healthcare providers. The packaging is designed to maintain product integrity, prevent contamination, and ensure ease of use.
Commitment to Quality
Biophar Lifesciences prioritizes quality and safety. Each batch of Nopgtus Syrup undergoes extensive testing, including:
- Active ingredient purity verification
- Microbial contamination checks
- Stability under varying storage conditions
- Consistency in texture and taste
This rigorous quality control ensures that patients receive a reliable product and partners can market Nopgtus Syrup with confidence.
Why Choose Biophar Lifesciences?
- Expertise: Years of experience in pharmaceutical manufacturing and research.
- Innovative Formulations: Products like Nopgtus Syrup are developed with a focus on efficacy and patient compliance.
- Market Support: Comprehensive marketing and sales assistance for franchise and third-party partners.
- Regulatory Compliance: Manufacturing follows WHO-GMP and other international pharmaceutical standards.
Conclusion
Nopgtus Syrup by Biophar Lifesciences is a trusted, effective, and patient-friendly solution for managing cough, congestion, and bronchial conditions. Its combination of PCD Pharma Franchise Ambroxol Hydrochloride 30 Mg, Guaiphenesin 50 Mg & Levosalbutamol Sulphate 1 Mg Syrup provides comprehensive respiratory relief while ensuring safety and compliance with international standards.
For medical professionals, it offers a reliable treatment option; for entrepreneurs, it provides an excellent PCD Pharma Franchise opportunity; and for businesses, it is a premium third-party manufacturing option. With high demand, proven efficacy, and a patient-friendly formulation, Nopgtus Syrup stands out in the respiratory care segment.
